Peptides DB
Research-centric peptide and protocol reference hub
Study 29 of 30L-Carnitine (Levocarnitine) literatureComparative biochemistry and physiology. Toxicology & pharmacology : CBP · Observational2026

Citalopram modulates hypothalamic appetite-related signalling and hepatic lipid metabolism in rainbow trout.

Citalopram exposure in rainbow trout alters appetite regulation and lipid metabolism, with effects varying by administration route.

Read at Comparative biochemistry and physiology. Toxicology & pharmacology : CBPAdd to compare

Where it sits

this study against the rest of the l-carnitine (levocarnitine) corpus
5
Preclinical
20
Observational · this one
0
Open-label
3
Randomised
2
Reviews

Summary and findings

This study measured the effects of citalopram on appetite regulation and hepatic energy metabolism in rainbow trout using chronic dietary administration and acute intraperitoneal injection. The findings indicated that both exposure routes upregulated hypothalamic npy mRNA abundance, while intraperitoneal injection also downregulated pomca1. Additionally, dietary exposure increased hepatic ATP-citrate lyase mRNA and activity.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Intraperitoneal injection induced hyperglycemia.2026

Abstract

The authors’ words, as Comparative biochemistry and physiology. Toxicology & pharmacology : CBP supplied them

Citalopram, a selective serotonin reuptake inhibitor prescribed for depression in humans, is increasingly detected in freshwater ecosystems alongside other contaminants of emerging concern, posing risks to non-target species. Here, we investigated the impact of citalopram on appetite regulation and hepatic energy metabolism in rainbow trout (Oncorhynchus mykiss) using two exposure routes: chronic dietary administration (0.01 and 0.02 μg/g feed for 10 days) and acute intraperitoneal injection (10 μg/g bw). Plasma metabolite (glucose, lactate, triglyceride, and non-esterified fatty acids-NEFAs-) levels, mRNA abundance of appetite-regulating factors in hypothalamus and gastrointestinal tract, and hepatic enzyme activities and mRNA abundance related to glucose and lipid metabolism were assessed. Both exposure routes upregulated hypothalamic npy (neuropeptide Y) mRNA abundance-a potent orexigenic factor-, while intraperitoneal injection additionally downregulated anorexigenic pomca1 (pro-opiomelanocortin), suggesting an orexigenic nature of citalopram, though with divergent modulation of energy sensors and transcription factors (prkaa2-AMP-activated protein kinase α2, Ampkα2-, mtor-mechanistic target of rapamycin-, and creb1-cAMP response element-binding protein-). Dietary exposure increased hepatic ATP-citrate lyase (Acly) mRNA and activity, whereas intraperitoneal administration upregulated fasn (fatty acid synthase) but downregulated cpt1b (carnitine palmitoyltransferase 1) and pklr (pyruvate kinase, Pk) levels, favoring lipogenesis over fatty acid oxidation. Dietary citalopram did not affect plasma metabolites, whereas intraperitoneal injection induced hyperglycemia and reduced NEFAs. Collectively, these findings demonstrate that citalopram exposure subtly reshapes neuroendocrine appetite regulation and hepatic lipid metabolism in rainbow trout in a route-dependent manner. These alterations may have ecological implications for fish populations in polluted habitats.

Background

This paper investigates the effects of citalopram, a selective serotonin reuptake inhibitor, on appetite regulation and hepatic metabolism in rainbow trout. Previous research has indicated that pharmaceuticals can disrupt endocrine functions in aquatic species, raising concerns about ecological impacts. Understanding these effects is crucial as citalopram is increasingly found in freshwater ecosystems.

Methods

The study employed two exposure routes: chronic dietary administration at 0.01 and 0.02 μg/g feed for 10 days and acute intraperitoneal injection at 10 μg/g body weight. The population studied was rainbow trout (Oncorhynchus mykiss). Primary outcome measures included plasma metabolite levels, mRNA abundance of appetite-regulating factors, and hepatic enzyme activities.

Results

Both exposure routes resulted in upregulation of hypothalamic npy mRNA abundance. The intraperitoneal injection also downregulated anorexigenic pomca1. Dietary exposure increased hepatic ATP-citrate lyase mRNA and activity, while intraperitoneal administration upregulated fasn but downregulated cpt1b and pklr levels. Notably, dietary citalopram did not affect plasma metabolites, whereas intraperitoneal injection induced hyperglycemia and reduced NEFAs.

Interpretation

The findings indicate that citalopram exposure can alter appetite regulation and lipid metabolism in rainbow trout, with different effects based on the route of administration. While the results are statistically significant, the clinical relevance for human health remains unclear due to the study's focus on a non-human species. Limitations such as the lack of long-term ecological data and species differences may confound the conclusions.

Key findings

  • 0.01 and 0.02 μg/g feed for 10 days for dietary exposure.
  • 10 μg/g body weight for acute intraperitoneal injection.
  • Upregulated hypothalamic npy mRNA abundance.
  • Intraperitoneal injection induced hyperglycemia and reduced NEFAs.
  • Dietary exposure did not affect plasma metabolites.

Limitations

  • Focus on non-target species, limiting human applicability.
  • Short-term study with only 10-day exposure.
  • No long-term ecological impact data reported.
  • Single-species study may not represent broader ecosystem effects.

Elsewhere in the L-Carnitine (Levocarnitine) corpus

CMetabolic identification of carnitine biomarkers for the differential diagnosis of uterine disorders in bitches.Theriogenology · 2026 · n=39 · Not reported in abstract.AnimalAPhytosterol-enriched corn and wheat germ blended oil improves lipid metabolism in hyperlipidemia via the AMPK/PPARα/CPT1 pathway.Food research international (Ottawa, Ont.) · 2026 · n=60 · Not reported in abstract.reviewCIntegrating in vivo metabolism, pharmacokinetics, and dual-indicator scoring for PK-marker selection of Celosiae Semen saponins.Journal of pharmaceutical and biomedical analysis · 2026 · AUC₀-∞ was 215.45 μg·min/mL.AnimalCCPT1A alters granulosa cell proliferation and steroidogenic activity in association with fatty acid oxidation during goat follicular development.Theriogenology · 2026 · Not reported in abstract.AnimalCIntegrative single-cell and bulk transcriptome analyses reveal a carnitine-related prognostic signature and fibroblast plasticity in HNSCCbiorxiv-preprint · 2026 · The risk model achieved 1-, 3-, and 5-year AUC values of 0.65, 0.66, and 0.65 in the training set.In vitroDThe protective effect of chemical and natural compounds against amiodarone induced toxicity: A systematic review.Biochemistry and biophysics reports · 2026 · Not reported in abstract.review